Sarah Palmer
Sarah Palmer
Unknown affiliation
Verified email at
Cited by
Cited by
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
S Palmer, F Maldarelli, A Wiegand, B Bernstein, GJ Hanna, SC Brun, ...
Proceedings of the National Academy of Sciences 105 (10), 3879-3884, 2008
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Q Yu, R König, S Pillai, K Chiles, M Kearney, S Palmer, D Richman, ...
Nature structural & molecular biology 11 (5), 435-442, 2004
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer, AP Wiegand, F Maldarelli, H Bazmi, JAM Mican, M Polis, ...
Journal of clinical microbiology 41 (10), 4531-4536, 2003
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
G Lehrman, IB Hogue, S Palmer, C Jennings, CA Spina, A Wiegand, ...
The Lancet 366 (9485), 549-555, 2005
Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction
DE Kaufmann, DG Kavanagh, F Pereyra, JJ Zaunders, EW Mackey, ...
Nature immunology 8 (11), 1246-1254, 2007
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
M J Buzón, M Massanella, JM Llibre, A Esteve, V Dahl, MC Puertas, ...
Nature medicine 16 (4), 460-465, 2010
Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control
SA Migueles, CM Osborne, C Royce, AA Compton, RP Joshi, KA Weeks, ...
Immunity 29 (6), 1009-1021, 2008
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies
S Eriksson, EH Graf, V Dahl, MC Strain, SA Yukl, ES Lysenko, RJ Bosch, ...
PLoS pathogens 9 (2), e1003174, 2013
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis
S Palmer, M Kearney, F Maldarelli, EK Halvas, CJ Bixby, H Bazmi, D Rock, ...
Journal of clinical microbiology 43 (1), 406-413, 2005
Towards an HIV cure: a global scientific strategy
Nature reviews Immunology 12 (8), 607-614, 2012
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical …
TA Rasmussen, M Tolstrup, CR Brinkmann, R Olesen, C Erikstrup, ...
The lancet HIV 1 (1), e13-e21, 2014
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
JB Dinoso, SY Kim, AM Wiegand, SE Palmer, SJ Gange, L Cranmer, ...
Proceedings of the National Academy of Sciences 106 (23), 9403-9408, 2009
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy
JH Elliott, F Wightman, A Solomon, K Ghneim, J Ahlers, MJ Cameron, ...
PLoS pathogens 10 (11), e1004473, 2014
International AIDS Society global scientific strategy: towards an HIV cure 2016
SG Deeks, SR Lewin, AL Ross, J Ananworanich, M Benkirane, P Cannon, ...
Nature medicine 22 (8), 839-850, 2016
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia
F Maldarelli, S Palmer, MS King, A Wiegand, MA Polis, JA Mican, ...
PLoS pathogens 3 (4), e46, 2007
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial
RT Gandhi, L Zheng, RJ Bosch, ES Chan, DM Margolis, S Read, ...
PLoS medicine 7 (8), e1000321, 2010
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient
SA Yukl, E Boritz, M Busch, C Bentsen, TW Chun, D Douek, E Eisele, ...
PLoS pathogens 9 (5), e1003347, 2013
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time
L Josefsson, S von Stockenstrom, NR Faria, E Sinclair, P Bacchetti, ...
Proceedings of the National Academy of Sciences 110 (51), E4987-E4996, 2013
Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants
B Hiener, BA Horsburgh, JS Eden, K Barton, TE Schlub, E Lee, ...
Cell reports 21 (3), 813-822, 2017
Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy
D McMahon, J Jones, A Wiegand, SJ Gange, M Kearney, S Palmer, ...
Clinical infectious diseases 50 (6), 912-919, 2010
The system can't perform the operation now. Try again later.
Articles 1–20